Hirsutism Clinical Trial
NCT number | NCT00371930 |
Other study ID # | 1742-03/06 |
Secondary ID | |
Status | Not yet recruiting |
Phase | Phase 1/Phase 2 |
First received | September 1, 2006 |
Last updated | June 2, 2008 |
24 test persons are treated with a dye suspension followed by a laser intervention. A decrease of hair density is expected.
Status | Not yet recruiting |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - age 18-60 Exclusion Criteria: - anormal behavior - pregnancy - pathologic skin conditions - medication that my interfere with the study - allergy against the photosensitizer - lack of compliance - other reasons considered important by the investigator |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind
Country | Name | City | State |
---|---|---|---|
Germany | FSU Jena, Dept. of Dermatology | Jena | Thuringia |
Lead Sponsor | Collaborator |
---|---|
University of Jena |
Germany,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02103608 -
Clinical Evaluation of Silk'n Glide for Face
|
N/A | |
Not yet recruiting |
NCT00495443 -
Enhanced Safety Aesthetic Laser System
|
N/A | |
Not yet recruiting |
NCT06003062 -
Suppression of Upper Lip Hair Growth Using Novel Hemp Extract
|
||
Active, not recruiting |
NCT00145288 -
Prospective Study of Patients With Hirsutism
|
Phase 2/Phase 3 | |
Completed |
NCT00152048 -
Evaluation of Eflornithine on Facial and Forearm Skin
|
Phase 4 | |
Enrolling by invitation |
NCT01461694 -
Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT00441948 -
Enhanced Safety Laser Hair Removal System
|
N/A | |
Completed |
NCT03673995 -
Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS
|
N/A | |
Recruiting |
NCT04979377 -
Prevalence of Hyperandrogenism in Type 1 Diabetes
|
||
Completed |
NCT02494297 -
DUS on the Prescribing Indications for CPA/EE in 5 European Countries
|
||
Completed |
NCT00960310 -
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions
|
Phase 1 | |
Completed |
NCT02793557 -
Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth
|
Phase 1/Phase 2 | |
Completed |
NCT01555190 -
Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone
|
N/A | |
Completed |
NCT01817894 -
Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism
|
Phase 4 | |
Completed |
NCT00143052 -
Bone Status and Insulin Resistance in Hirsutism
|
N/A | |
Recruiting |
NCT01338519 -
Database Study on Patients With PCOS
|
N/A | |
Recruiting |
NCT04292587 -
Prevalence of Hirsutism in Turkey: Data of The Dermatoendocrinology Study Group
|
||
Completed |
NCT00959335 -
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions
|
Phase 1 |